Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-27T18:32:59.705Z Has data issue: false hasContentIssue false
  • English
  • Français

Antiviral use in healthcare workers—A systematic review

Published online by Cambridge University Press:  15 March 2021

Fazia Tadount ,
Zineb Laghdir  and
Caroline Quach Open the ORCID record for Caroline Quach [Opens in a new window]
Fazia Tadount
Affiliation:
Research Institute, CHU Sainte-Justine, Montreal, Québec, Canada Infection Prevention & Control, CHU Sainte-Justine, Montreal, Québec, Canada
Zineb Laghdir
Affiliation:
Research Institute, CHU Sainte-Justine, Montreal, Québec, Canada Infection Prevention & Control, CHU Sainte-Justine, Montreal, Québec, Canada
Caroline Quach*
Affiliation:
Research Institute, CHU Sainte-Justine, Montreal, Québec, Canada Infection Prevention & Control, CHU Sainte-Justine, Montreal, Québec, Canada Department of Pediatric Laboratory Medicine, CHU Sainte-Justine, Montreal, Québec, Canada Department of Microbiology, Infectious Diseases, and Immunology, Faculty of Medicine, University of Montreal, Montreal, Québec, Canada
*
Author for correspondence: Caroline Quach. E-mail: c.quach@umontreal.ca
Get access Rights & Permissions [Opens in a new window]

Abstract

Neuraminidase inhibitors (NAIs) are likely part of the rapid response and control in influenza pandemics and institutional outbreaks. We conducted a systematic review to appraise the current evidence on the use of NAIs among healthcare workers in the context of an influenza pandemic.

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 43 , Issue 4 , April 2022 , pp. 518 - 523
Check for updates
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

PREVIOUS PRESENTATION. A poster presentation of this article was presented at the AMMI Canada CACMID 2020 virtual conference on April 29th, 2020, in Vancouver, BC, Canada.

References

Carrasco, LR, Lee, VJ, Chen, MI, Matchar, DB, Thompson, JP, Cook, AR. Strategies for antiviral stockpiling for future influenza pandemics: a global epidemic-economic perspective. J Roy Soc Interface 2011;8:1307–1313.CrossRefGoogle ScholarPubMed
Hota, S, McGeer, A. Antivirals and the control of influenza outbreaks. Clin Infect Dis 2007;45:1362–1368.CrossRefGoogle ScholarPubMed
Coleman, BL, Boggild, AK, Drews, SJ, Li, Y, Low, DE, McGeer, AJ. Respiratory illnesses in Canadian healthcare workers: a pilot study of influenza vaccine and oseltamivir prophylaxis during the 2007/2008 influenza season. Influenza Other Respir Viruses 2011;5:404–408.CrossRefGoogle ScholarPubMed
Booy, R, Lindley, RI, Dwyer, DE, et al. Treating and preventing influenza in aged care facilities: a cluster randomised controlled trial. PLoS One 2012;7:e46509–e46509.CrossRefGoogle Scholar
Samra, T, Pawar, M. Health care personnel and risk of H1N1-chemoprophylaxis with oseltamivir. Indian J Pharmacol 2012;44:754–758.CrossRefGoogle ScholarPubMed
Anekthananon, T, Pukritayakamee, S, Ratanasuwan, W, et al. Oseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks. J Antimicrob Chemother 2012;68:697–707.CrossRefGoogle ScholarPubMed
Coleman, BL, Fadel, SA, Drews, SJ, Hatchette, TF, McGeer, AJ. Zanamivir versus trivalent split virus influenza vaccine: a pilot randomized trial. Influenza Other Respir Viruses 2015;9:78–84.CrossRefGoogle ScholarPubMed
Querci, M, Stryjewski, ME, Herrera, F, et al. Healthcare personnel infected with novel influenza A H1N1 virus in university hospitals in Buenos Aires, Argentina. Scand J Infect Dis 2011;43:70–74.CrossRefGoogle ScholarPubMed
Cheng, VC, Tai, JW, Wong, LM, et al. Prevention of nosocomial transmission of swine-origin pandemic influenza virus A/H1N1 by infection control bundle. J Hosp Infect 2010;74:271–277.CrossRefGoogle ScholarPubMed
Higa, F, Tateyama, M, Tomishima, M, et al. Role of neuraminidase inhibitor chemoprophylaxis in controlling nosocomial influenza: an observational study. Influenza Other Respir Viruses 2012;6:299–303.CrossRefGoogle ScholarPubMed
Supplementary material: File

Tadount et al. supplementary material

Tadount et al. supplementary material

Download Tadount et al. supplementary material(File)
File 239.4 KB